Kaveh Zakeri

Memorial Sloan Kettering Cancer Center

Papers

2

Total Citations

81

H-Index

2

About

Dr. Kaveh Zakeri is a leading voice in radiation oncology, whose research centers on the precision treatment of head and neck cancers, particularly human papillomavirus (HPV)-associated oropharyngeal cancer. His major contributions lie in the complex field of treatment de-intensification—strategies designed to reduce the severe, long-term toxicities of chemoradiation without compromising the excellent cure rates for HPV-positive patients. Dr. Zakeri has critically analyzed the landscape of clinical trials, explaining why some de-escalation approaches (like substituting cisplatin with cetuximab) have failed, while charting a path forward for more promising strategies. His highly cited 2022 consensus paper, with 57 citations, synthesizes expert agreement and controversy, serving as a crucial roadmap for clinicians and researchers. By identifying the past failures and future promise of these trials, Dr. Zakeri’s work directly shapes safer, more effective treatment paradigms, aiming to preserve both quality of life and survival for a growing patient population.

Research Focus

Key Achievements

2
H-Index
2
Papers
81
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer
57 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago